Qingwen Wang

2.2k total citations
75 papers, 1.3k citations indexed

About

Qingwen Wang is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Qingwen Wang has authored 75 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Rheumatology and 18 papers in Immunology. Recurrent topics in Qingwen Wang's work include Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Salivary Gland Disorders and Functions (6 papers). Qingwen Wang is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Salivary Gland Disorders and Functions (6 papers). Qingwen Wang collaborates with scholars based in China, Hong Kong and United States. Qingwen Wang's co-authors include Jian Chen, Xian Lin, Yiping Hu, Cheng Tao, Xianghua Huang, Qianqian Wang, Zhihong Liu, Juan He, Juan He and David Wood and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Qingwen Wang

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingwen Wang China 21 596 287 204 190 167 75 1.3k
Raghunatha R. Yammani United States 21 633 1.1× 528 1.8× 171 0.8× 177 0.9× 107 0.6× 35 1.3k
Huan Li China 21 615 1.0× 108 0.4× 269 1.3× 160 0.8× 196 1.2× 86 1.5k
Te‐Mao Li Taiwan 24 555 0.9× 163 0.6× 125 0.6× 185 1.0× 207 1.2× 53 1.3k
Sarah E. Headland United Kingdom 8 659 1.1× 150 0.5× 498 2.4× 237 1.2× 114 0.7× 13 1.3k
Mark Warnock United States 16 323 0.5× 185 0.6× 141 0.7× 194 1.0× 102 0.6× 33 1.4k
Weimin Fan China 24 561 0.9× 293 1.0× 113 0.6× 165 0.9× 326 2.0× 68 1.7k
Nada Alaaeddine Lebanon 21 363 0.6× 470 1.6× 180 0.9× 223 1.2× 248 1.5× 46 1.4k
Yi He China 25 707 1.2× 649 2.3× 486 2.4× 181 1.0× 187 1.1× 88 1.9k
Pei‐Ling Chi Taiwan 23 561 0.9× 86 0.3× 234 1.1× 200 1.1× 92 0.6× 42 1.2k
Igor Bendik Switzerland 21 991 1.7× 150 0.5× 148 0.7× 111 0.6× 152 0.9× 44 2.2k

Countries citing papers authored by Qingwen Wang

Since Specialization
Citations

This map shows the geographic impact of Qingwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingwen Wang more than expected).

Fields of papers citing papers by Qingwen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingwen Wang. The network helps show where Qingwen Wang may publish in the future.

Co-authorship network of co-authors of Qingwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingwen Wang. A scholar is included among the top collaborators of Qingwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingwen Wang. Qingwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chai, Jinwei, Jinqiao Li, Jiali Li, et al.. (2025). The first Ranatuerin antimicrobial peptide with LPS-neutralizing and anti-inflammatory activities in vitro and in vivo. Life Sciences. 363. 123375–123375.
2.
Wang, Xichen, et al.. (2024). MAVS: The next STING in cancers and other diseases. Critical Reviews in Oncology/Hematology. 207. 104610–104610. 4 indexed citations
3.
Zhao, Meng, Yuxin Li, Bihua Xu, et al.. (2024). Ion channel TRPV2 is critical in enhancing B cell activation and function. The Journal of Experimental Medicine. 221(3). 13 indexed citations
4.
Gan, Yuzhou, Bo Huang, Hongjiang Liu, et al.. (2024). A GITRL‐mTORC1‐GM‐CSF Positive Loop Promotes Pathogenic Th17 Response in Primary Sjögren Syndrome. Arthritis & Rheumatology. 76(9). 1419–1430. 1 indexed citations
5.
Zhang, Wei, Song Luo, Qian Zhu, et al.. (2024). Lead exposure induces autophagy via TLR4/EEF2 in neurons. Food and Chemical Toxicology. 189. 114734–114734. 3 indexed citations
6.
Lin, Xian, Jian Chen, Cheng Tao, et al.. (2023). Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease. SHILAP Revista de lepidopterología. 4(2). e219–e219. 22 indexed citations
7.
Lin, Xian, et al.. (2023). Artemisinins: Promising drug candidates for the treatment of autoimmune diseases. Medicinal Research Reviews. 44(2). 867–891. 21 indexed citations
8.
Zheng, Fengping, Donge Tang, Shanshan Li, et al.. (2023). Spatial proteomics landscape and immune signature analysis of renal sample of lupus nephritis based on laser-captured microsection. Inflammation Research. 72(8). 1603–1620. 6 indexed citations
9.
He, Jiaxin, Xian Lin, Xiaocheng Wang, et al.. (2023). Arecoline hydrobromide suppresses PI3K/AKT pathway in rheumatoid arthritis synovial fibroblasts and relieves collagen-induced arthritis in mice. International Immunopharmacology. 124(Pt B). 110925–110925. 10 indexed citations
10.
Chen, Jian, Xian Lin, Juan He, et al.. (2023). CT2-3 induces cell cycle arrest and apoptosis in rheumatoid arthritis fibroblast-like synoviocytes through regulating PI3K/AKT pathway. European Journal of Pharmacology. 956. 175871–175871. 7 indexed citations
11.
Cai, Wenqian, Fan Liao, Ruiqi Li, et al.. (2022). Modulating Lysine Crotonylation in Cardiomyocytes Improves Myocardial Outcomes. Circulation Research. 131(5). 456–472. 47 indexed citations
12.
Chen, Jian, et al.. (2022). Shikonin alleviates collagen-induced arthritis mice by inhibiting M1 macrophage polarization.. PubMed. 42(6). 932–939. 8 indexed citations
13.
He, Juan, et al.. (2021). Shikonin attenuates rheumatoid arthritis by targeting SOCS1/JAK/STAT signaling pathway of fibroblast like synoviocytes. Chinese Medicine. 16(1). 96–96. 22 indexed citations
14.
Chen, Lianzhi, Guangyi Li, Jun Yuan, et al.. (2020). Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading. Journal of Orthopaedic Translation. 24. 66–75. 107 indexed citations
15.
He, Juan, Han Wang, Yiping Hu, et al.. (2020). ErMiao San Inhibits Angiogenesis in Rheumatoid Arthritis by Suppressing JAK/STAT Signaling Pathways. Evidence-based Complementary and Alternative Medicine. 2020(1). 15 indexed citations
16.
Hu, Yiping, Tiantian Zhang, Wenxiang Cheng, et al.. (2020). Downregulation of Hypoxia-Inducible Factor-1α by RNA Interference Alleviates the Development of Collagen-Induced Arthritis in Rats. Molecular Therapy — Nucleic Acids. 19. 1330–1342. 33 indexed citations
17.
Liu, Chunfang, Jingxia Wang, Qianqian Wang, et al.. (2020). Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. Journal of Ethnopharmacology. 260. 113039–113039. 96 indexed citations
18.
Song, Congkuan, Zixin Guo, Donghu Yu, et al.. (2020). A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma. Frontiers in Oncology. 10. 1300–1300. 64 indexed citations
19.
Xiao, Fan, Xiang Lin, Jie Tian, et al.. (2017). Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren’s syndrome. Cellular and Molecular Immunology. 14(11). 924–934. 48 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raghunatha R. Yammani Breakdown of academic impact, for papers by Huan Li Breakdown of academic impact, for papers by Te‐Mao Li Breakdown of academic impact, for papers by Sarah E. Headland Breakdown of academic impact, for papers by Mark Warnock Breakdown of academic impact, for papers by Weimin Fan Breakdown of academic impact, for papers by Nada Alaaeddine Breakdown of academic impact, for papers by Yi He Breakdown of academic impact, for papers by Pei‐Ling Chi Breakdown of academic impact, for papers by Igor Bendik
Rankless by CCL
2026